Systematic evaluation of markers used for the identification of human induced pluripotent stem cells
Open Access
- 15 January 2017
- journal article
- Published by The Company of Biologists in Biology Open
- Vol. 6 (1) , 100-108
Abstract
Low efficiency of somatic cell reprogramming and heterogeneity among human induced pluripotent stem cells (hiPSCs) demand extensive characterization of isolated clones before their use in downstream applications. By monitoring human fibroblasts undergoing reprogramming for their morphological changes and expression of fibroblast (CD13), pluripotency markers (SSEA-4 and TRA-1-60) and a retrovirally expressed red fluorescent protein (RV-RFP), we compared the efficiency of these features to identify bona fide hiPSC colonies. The co-expression kinetics of fibroblast and pluripotency markers in the cells being reprogrammed and the emerging colonies revealed the heterogeneity within SSEA-4+ and TRA-1-60+ cells, and the inadequacy of these commonly used pluripotency markers for the identification of bona fide hiPSC colonies. The characteristic morphological changes in the emerging hiPSC colonies derived from fibroblasts expressing RV-RFP showed a good correlation between hiPSC morphology acquisition and silencing of RV-RFP and facilitated the easy identification of hiPSCs. The kinetics of retroviral silencing and pluripotency marker expression in emerging colonies suggested that combining both these markers could demarcate the stages of reprogramming with better precision than with pluripotency markers alone. Our results clearly demonstrate that the pluripotency markers that are routinely analyzed for the characterization of established iPSC colonies are not suitable for the isolation of pluripotent cells in the early stages of reprogramming, and silencing of retrovirally expressed reporter genes helps in the identification of colonies that have attained a pluripotent state and the morphology of human embryonic stem cells (hESCs).Keywords
Funding Information
- Department of Biotechnology, Ministry of Science and Technology (BT/PR12793/MED/31/76/2009)
- Council of Scientific and Industrial Research (321279. F. No. 08/ 016(0041)/2009-EMR-I)
- University Grants Commission (319880. F. No. 10-2 (5)/2007(ii)-E.U.II)
This publication has 35 references indexed in Scilit:
- The promise of induced pluripotent stem cells in research and therapyNature, 2012
- Donor cell type can influence the epigenome and differentiation potential of human induced pluripotent stem cellsNature Biotechnology, 2011
- Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cellsNature Biotechnology, 2010
- Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cellsNature, 2009
- Efficient and rapid generation of induced pluripotent stem cells from human keratinocytesNature Biotechnology, 2008
- Disease-Specific Induced Pluripotent Stem CellsCell, 2008
- Defining Molecular Cornerstones during Fibroblast to iPS Cell Reprogramming in MouseCell Stem Cell, 2008
- Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined FactorsCell, 2007
- Generation of germline-competent induced pluripotent stem cellsNature, 2007
- Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined FactorsCell, 2006